Haystack Oncology Launches with $56 Million in Series A Financing to Accelerate Adoption of Post-Op Cancer Detection Technology and Optimize Cancer Therapy Monitoring and Treatment

/PRNewswire/ -- Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to...

Related Keywords

Germany ,New York ,United States ,Hamburg ,Alexandria ,Al Iskandariyah ,Egypt ,London ,City Of ,United Kingdom ,American ,Isaac Ro ,Diamantis Xylas ,Dan Edelstein ,Joshua Cohen ,George Petrocheilos ,Bert Vogelstein ,Nick Papadopoulos ,Ken Kinzler ,Jacob Vogelstein ,Frank Holtrup ,Johns Hopkins University ,Detection Corp ,Catalio Head Of Research ,Johns Hopkins Kimmel Cancer Center ,Ludwig Center ,American Society Of Clinical Oncology ,Catalio Capital ,Catalio Capital Management ,Exact Ventures ,Exact Sciences ,Alexandria Venture ,American Society ,Clinical Oncology ,New England Journal ,Haystack Duo ,Thrive Earlier Detection Corp ,Chief Financial Officer ,Thrive Earlier Detection ,Executive Chairman ,Managing Partner ,Capital Management ,Guiding Adjuvant Therapy ,Haystack Oncology ,